Sort   by:  
 Page size 
UnknownPhase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.
Not available
S-EPMC3983818 | biostudies-literature
UnknownIntegrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.
Not available
S-EPMC9310611 | biostudies-literature
UnknownImmunometabolic interference between cancer and COVID-19.
Not available
S-EPMC10090695 | biostudies-literature
UnknownBrain-Derived Neurotrophic Factor, Kynurenine Pathway, and Lipid-Profiling Alterations as Potential Animal Welfare Indicators in Dairy Cattle.
Not available
S-EPMC10093196 | biostudies-literature
UnknownA vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.
Not available
S-EPMC8298945 | biostudies-literature
UnknownATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
Not available
S-EPMC4775342 | biostudies-literature
UnknownHFE p.H63D polymorphism does not influence ALS phenotype and survival.
Not available
S-EPMC5183653 | biostudies-literature
UnknownClinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).
Not available
S-EPMC12657748 | biostudies-literature
UnknownCommon and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Not available
S-EPMC8648564 | biostudies-literature
Sort   by:  
 Page size